- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Jeena Sikho Lifecare kicked off FY26 with robust Q1 performance. Revenue from operations surged to ₹174.29 Cr, marking a strong 74% YoY growth, driven by significant scale-up in Private Panchkarma services and continued momentum in Medicine sales. Profit after tax (PAT) jumped an impressive 218% YoY to ₹51.31 Cr, with EBITDA margins expanding significantly to 45%. Earnings per share (EPS) also saw a 218% YoY rise to ₹4.13.
Growth was fueled by higher IPD (in-patient) and OPD (out-patient) patient volumes, growing 46% and 68% YoY respectively. The company added 391 new beds in Q1, laying a solid foundation for future growth. Strategically, JSLL is shifting focus towards the more profitable Private Panchkarma segment to improve cash conversion. They also launched the 'Pet Yakrit Pleeha Shuddhi Kit' and successfully migrated to the NSE and BSE mainboard, enhancing market visibility. Management is confident that strategic initiatives and expanded capacity will drive sustainable growth.